Inhibitory effects of commonly used herbal extracts on UGT1A1 enzyme activity

被引:45
|
作者
Mohamed, Mohamed-Eslam F. [1 ]
Tseng, Tiffany [1 ]
Frye, Reginald E. [1 ]
机构
[1] Univ Florida, Coll Pharm, Dept Pharmacotherapy & Translat Res, Gainesville, FL 32610 USA
关键词
Green tea; EGCG; milk thistle; UGT1A1; estradiol glucuronidation; inhibition; IN-VITRO; UDP-GLUCURONOSYLTRANSFERASE; LIQUID-CHROMATOGRAPHY; DRUG INTERACTIONS; GLUCURONIDATION; ESTRADIOL; PHARMACOKINETICS; CONJUGATION; METABOLISM; RALOXIFENE;
D O I
10.3109/00498254.2010.505669
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. Commonly used herbal supplements were screened for their potential to inhibit UGT1A1 activity using human liver microsomes. Extracts screened included ginseng, echinacea, black cohosh, milk thistle, garlic, valerian, saw palmetto, and green tea epigallocatechin gallate (EGCG). Estradiol-3-O-glucuronide (E-3-G) formation was used as the index of UGT1A1 activity. 2. All herbal extracts except garlic showed inhibition of UGT1A1 activity at one or more of the three concentrations tested. A volume per dose index (VDI) was calculated to estimate the volume in which the daily dose should be diluted to obtain an IC50-equivalent concentration. EGCG, echinacea, saw palmetto, and milk thistle had VDI values >2.0L per dose unit, suggesting a higher potential for interaction. 3. Inhibition curves were constructed for EGCG, echinacea, saw palmetto, and milk thistle. IC50 values were (mean +/- SE) 7.8 +/- 0.9, 211.7 +/- 43.5, 55.2 +/- 9.2, and 30.4 +/- 6.9 mu g/ml for EGCG, echinacea, saw palmetto, and milk thistle extracts, respectively. 4. Based on our findings, inhibition of UGT1A1 by milk thistle and EGCG and to a lesser extent by echinacea and saw palmetto is plausible, particularly in the intestine where higher extract concentrations are anticipated. Further clinical studies are warranted.
引用
收藏
页码:663 / 669
页数:7
相关论文
共 50 条
  • [21] TaqMan real time PCR for the Detection of the Gilbert’s Syndrome Markers UGT1A1*28; UGT1A1*36 and UGT1A1*37
    Valentina Daprà
    Carla Alliaudi
    Ilaria Galliano
    Maddalena Dini
    Giada Lo Curcio
    Cristina Calvi
    Marialaura Archetti
    Martina Gavatorta
    Massimiliano Bergallo
    Molecular Biology Reports, 2021, 48 : 4953 - 4959
  • [22] Linkage disequilibrium of UGT1A1*6 and UGT1A1*28 in relation to UGT1A6 and UGT1A7 polymorphisms
    Urawa, Naohito
    Kobayashi, Yoshinao
    Araki, Jun
    Sugimoto, Ryosuke
    Iwasa, Motoh
    Kaito, Masahiko
    Adachi, Yukihko
    ONCOLOGY REPORTS, 2006, 16 (04) : 801 - 806
  • [23] Effects of Shengjiangxiexin decoction on irinotecan-induced toxicity in patients with UGT1A1*28 and UGT1A1*6 polymorphisms
    Deng Bo
    Jia Liqun
    Tan Huangying
    Lou Yanni
    Li Xue
    Li Yuan
    Yu Lili
    JOURNAL OF TRADITIONAL CHINESE MEDICINE, 2017, 37 (01) : 35 - 42
  • [24] EFFECTS OF UGT1A1 GENETIC POLYMORPHISM ON THE PHARMACOKINETICS OF EZETIMIBE
    Choi, C., I
    Bae, J. W.
    Kim, M. J.
    Jang, C. G.
    Lee, S. Y.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 79 - 79
  • [25] Variation in UGT1A1 activity in Gilbert's syndrome - Reply
    Peters, WHM
    Raijmakers, MTM
    Steegers, EAP
    Jansen, PLM
    JOURNAL OF HEPATOLOGY, 2001, 34 (04) : 637 - 638
  • [26] Inhibition of UGT1A1*1 and UGT1A1*6 catalyzed glucuronidation of SN-38 by silybins
    Li, Wei
    Chen, Yin-Nan
    Chen, Yue-Yue
    Wang, Zhe
    Wang, Zhen
    Jiang, Li-Li
    Shi, Hong-Can
    Liu, Yong
    CHEMICO-BIOLOGICAL INTERACTIONS, 2022, 368
  • [27] Severe irinotecan-induced toxicity in a patient with UGT1A1*28 and UGT1A1*6 polymorphisms
    Xu, Jian-Ming
    Wang, Yan
    Ge, Fei-Jiao
    Lin, Li
    Liu, Ze-Yuan
    Sharma, Manish R.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (24) : 3899 - 3903
  • [28] Neobavaisoflavone Induces Bilirubin Metabolizing Enzyme UGT1A1 via PPARα and PPARγ
    Zhu, Ya-Di
    Guan, Xiao-Qing
    Chen, Jing
    Peng, Sheng
    Finel, Moshe
    Zhao, Ying-Yuan
    Wang, Rui-Min
    Bi, Hui-Chang
    Lei, Ming
    Wang, Dan-Dan
    Ge, Guang-Bo
    FRONTIERS IN PHARMACOLOGY, 2021, 11
  • [29] The Inhibitory Effect of 20(S)-Protopanaxatriol (ppt) Towards UGT1A1 and UGT2B7
    He, Ya-Jun
    Fang, Zhong-Ze
    Ge, Guang-Bo
    Jiang, Peng
    Jin, Hui-Zi
    Zhang, Wei-Dong
    Yang, Ling
    PHYTOTHERAPY RESEARCH, 2013, 27 (04) : 628 - 632
  • [30] Effects of UGT1A1*28 polymorphism on raloxifene pharmacokinetics and pharmacodynamics
    Trontelj, Jurij
    Marc, Janja
    Zavratnik, Andrej
    Bogataj, Marija
    Mrhar, Ales
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 67 (04) : 437 - 444